Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexaria Bioscience Corp

0.2022
-0.0378-15.75%
Volume:104.00
Turnover:21.02
Market Cap:1.03M
PE:- -
High:0.2022
Open:0.2022
Low:0.2022
Close:0.2400
Loading ...

Company Profile

Company Name:
Lexaria Bioscience Corp
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.